• Revance Therapeutics (NASDAQ:RVNC) Earns "Neutral" Rating from HC Wainwright

    Source: Buzz FX / 08 Nov 2024 11:56:17   America/New_York


    Revance Therapeutics (NASDAQ:RVNC) Earns "Neutral" Rating from HC Wainwright Written by MarketBeat November 8, 2024 Share Link copied to clipboard. Revance Therapeutics ( NASDAQ:RVNC - Get Free Report ) 's stock had its "neutral" rating res
    Read more...
Share on,